CLLS Cellectis S.A. gains 31% Dec 30, 2019

Posted By: Rajesh Srivastava - Monday, December 30, 2019

Share

& Comment

Developing cancer immunotherapies based on gene-edited CAR T-cells.http://www.priceseries.com/trade/CLLS-Cellectis-SA-stock-gains-31-percent-a-Trade-Record-by-priceSeries-2019112120191230.html

About Rajesh Srivastava

Techism is an online Publication that complies Bizarre, Odd, Strange, Out of box facts about the stuff going around in the world which you may find hard to believe and understand. The Main Purpose of this site is to bring reality with a taste of entertainment

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Copyright © priceSeries Daily Results™ is a registered trademark.

Designed by Templateism. Hosted on Blogger Platform.